382 related articles for article (PubMed ID: 14977534)
1. Persistent and dormant tubercle bacilli and latent tuberculosis.
Zhang Y
Front Biosci; 2004 May; 9():1136-56. PubMed ID: 14977534
[TBL] [Abstract][Full Text] [Related]
2. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
[TBL] [Abstract][Full Text] [Related]
3. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
5. Delamanid Kills Dormant Mycobacteria
Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
[TBL] [Abstract][Full Text] [Related]
6. A dynamic reinfection hypothesis of latent tuberculosis infection.
Cardona PJ
Infection; 2009 Apr; 37(2):80-6. PubMed ID: 19308318
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Controlling strategy of dormant Mycobacterium tuberculosis.
Gan Y; Guo S
Chin Med J (Engl); 2014; 127(18):3316-21. PubMed ID: 25266533
[TBL] [Abstract][Full Text] [Related]
9. Exit from mycobacterial dormancy: a structural perspective.
Squeglia F; Ruggiero A; Berisio R
Curr Med Chem; 2015; 22(14):1698-709. PubMed ID: 25666798
[TBL] [Abstract][Full Text] [Related]
10. On the nature of Mycobacterium tuberculosis-latent bacilli.
Cardona PJ; Ruiz-Manzano J
Eur Respir J; 2004 Dec; 24(6):1044-51. PubMed ID: 15572551
[TBL] [Abstract][Full Text] [Related]
11. The significance of persisters in tuberculosis drug discovery: Exploring the potential of targeting the glyoxylate shunt pathway.
Negi A; Sharma R
Eur J Med Chem; 2024 Feb; 265():116058. PubMed ID: 38128237
[TBL] [Abstract][Full Text] [Related]
12. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
Marimani M; Ahmad A; Duse A
Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
[TBL] [Abstract][Full Text] [Related]
13. Dormant tubercle bacilli: the key to more effective TB chemotherapy?
Dick T
J Antimicrob Chemother; 2001 Jan; 47(1):117-8. PubMed ID: 11152444
[No Abstract] [Full Text] [Related]
14. Mycobacterial lipolytic enzymes: a gold mine for tuberculosis research.
Dedieu L; Serveau-Avesque C; Kremer L; Canaan S
Biochimie; 2013 Jan; 95(1):66-73. PubMed ID: 22819994
[TBL] [Abstract][Full Text] [Related]
15. New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.
Caño-Muñiz S; Anthony R; Niemann S; Alffenaar JC
Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187395
[TBL] [Abstract][Full Text] [Related]
16. New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
Salina EG; Ryabova O; Vocat A; Nikonenko B; Cole ST; Makarov V
J Infect Chemother; 2017 Nov; 23(11):794-797. PubMed ID: 28527650
[TBL] [Abstract][Full Text] [Related]
17. Is adipose tissue a place for Mycobacterium tuberculosis persistence?
Neyrolles O; Hernández-Pando R; Pietri-Rouxel F; Fornès P; Tailleux L; Barrios Payán JA; Pivert E; Bordat Y; Aguilar D; Prévost MC; Petit C; Gicquel B
PLoS One; 2006 Dec; 1(1):e43. PubMed ID: 17183672
[TBL] [Abstract][Full Text] [Related]
18.
Salina EG; Makarov V
Microorganisms; 2022 Nov; 10(12):. PubMed ID: 36557586
[TBL] [Abstract][Full Text] [Related]
19. Latent tuberculosis: interaction of virulence factors in Mycobacterium tuberculosis.
Sundararajan S; Muniyan R
Mol Biol Rep; 2021 Aug; 48(8):6181-6196. PubMed ID: 34351540
[TBL] [Abstract][Full Text] [Related]
20. The secret trumps, impelling the pathogenicity of tubercle bacilli.
Cardona PJ; Ivanyi J
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
